Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Shiba Inu token burn hits 6-month high — so why did SHIB drop 5%?

Shiba Inu token burn hits 6-month high — so why did SHIB drop 5%?

CryptonomistCryptonomist2026/07/17 08:06
By:Cryptonomist

Record token burns were supposed to be good news for Shiba Inu. On July 8, 2026, more than 110 million SHIB tokens were permanently removed from circulation — the largest single-day burn the project had seen in six months. The community celebrated. Then the price fell anyway.

Key takeaways

  • Shiba Inu burned more than 110 million SHIB on July 8, 2026, its biggest daily burn in six months, with weekly burns rising 56% to 152 million tokens.
  • Despite the record activity, large investors sold more than one trillion SHIB tokens onto exchanges, erasing the burn’s positive impact.
  • SHIB dropped roughly 5% on the day of the burn; monthly losses reached approximately 9%.
  • With approximately 585.6 trillion tokens still in circulation, supply reduction at this scale barely moves the needle.
  • Weak demand, not excess supply, is now the primary obstacle to any meaningful SHIB price recovery.

Record Shiba Inu Token Burns Reach Six-Month High

The numbers looked strong on paper. Weekly burns climbed to 152 million tokens, representing a rise of nearly 56% from the previous period. A wallet linked to Robinhood contributed the bulk of the July 8 activity, accounting for roughly 109 million of the tokens destroyed that day. Smaller holders added their share on top of that.

For a community that has long championed burn campaigns as a path to higher prices, this felt like a milestone. But the market’s response was immediate and unambiguous.

Massive Burns Fail to Reverse Price Decline Amid Whale Selling

SHIB fell around 5% on the same day the record burn was recorded. Monthly losses have reached roughly 9%, with price action stuck in a narrow range and no visible momentum building. The burn provided no floor.

Record Burn Overshadowed by Large Token Sales

The reason is straightforward, if uncomfortable: while the community was removing hundreds of millions of tokens, large investors moved more than one trillion SHIB onto trading platforms. That kind of selling pressure doesn’t just offset a 110-million-token burn — it buries it.

Whales are not accumulating. They are reducing exposure. That behavioral shift matters more than any single burn event, because it signals where sophisticated money thinks the token is headed.

Price Drops and Market Sentiment Worsen

Sentiment across the broader memecoin sector has continued to weaken alongside SHIB’s price struggles. Trader James Wynn went so far as to describe the token as “dead” — a subjective label, but one that reflects a mood that’s hard to ignore. When prominent voices in the space turn openly bearish, it tends to reinforce the very dynamics they’re describing.

Supply Reduction Alone Cannot Drive SHIB Price Recovery

The deeper problem with relying on burns becomes clear when you look at the full supply picture. Burn campaigns have produced real results in aggregate — but not nearly enough to matter at SHIB’s scale.

Circulating Supply Remains Extremely High

Even after years of community burn efforts, approximately 585.6 trillion SHIB tokens remain in circulation. Removing 152 million in a week, or even 110 million in a single day, represents a rounding error against that figure. The math simply doesn’t favor the burns as a price catalyst on their own.

Historical Burn by Vitalik Buterin Provides Context

The starkest illustration of this dynamic is historical. When Ethereum co-founder Vitalik Buterin received half of the original SHIB supply, he subsequently burned more than 410 trillion tokens in a single transaction. That one event still accounts for the vast majority of every token ever permanently removed from circulation. Everything the community has done since — including every record burn campaign — pales beside it.

Demand, Not Supply, Is the Primary Challenge

This is where the analysis gets critical. The instinct behind burn campaigns is sound in theory: reduce supply, increase scarcity, support price. But that mechanism only works if demand stays constant or grows. Right now, demand is the real problem — and no amount of burning fixes that directly.

Burn campaigns can shrink the available pool of tokens over time, but they cannot manufacture buyers. Until fresh demand returns to SHIB — whether from retail momentum, new utility, or broader crypto market enthusiasm — even the most aggressive supply reduction will struggle to produce durable price gains. The community’s efforts are not wasted, but they are fighting a much larger battle than most burn trackers reveal.

The divergence between what burns can do and what the market actually needs from SHIB has rarely been this visible. Record activity on the supply side, record indifference on the demand side. That gap is the real story — and it won’t be closed by burning more tokens.

FAQ

Why did Shiba Inu’s price drop despite a record token burn?

Large investors sold more than one trillion SHIB tokens onto exchanges on the same day, completely overwhelming the positive effect of the burn. The selling pressure from whales far exceeded what a 110-million-token removal could offset.

Has the increase in token burning successfully improved SHIB’s market sentiment?

No. Despite weekly burns rising 56% and a six-month high in daily burn activity, market sentiment continues to weaken for SHIB and across the broader memecoin sector.

What is the main obstacle to Shiba Inu’s price recovery?

Weak demand is the primary obstacle, not excess supply. Until stronger buying interest returns, burn campaigns alone are unlikely to generate lasting price gains.

How significant are the recent burns compared to historical burns?

The recent activity is minimal by comparison. Vitalik Buterin’s single burn of more than 410 trillion SHIB tokens still accounts for nearly all tokens ever permanently removed, dwarfing every community burn campaign combined.

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales